" class="no-js "lang="en-US"> John Drakenberg Renander - Medtech Alert
Friday, March 29, 2024
John Drakenberg Renander

John Drakenberg Renander

About John Drakenberg Renander

John is the CEO and co-founder of the AI powered Digital Therapeutics company Alex Therapeutics, an entrepreneur by heart with a degree in both Psychology and Business, and Oliver Fleetwood, PhD in Theoretical Computational Molecular Biophysics.

Related Story

Alex Therapeutics Raises €3.5M in Oversubscribed Financing round from Top Tier VC Investors to Advance Expansion in Europe and the US.

April 6 2022

Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a €3.5M funding round, led […]